|Bid||19.25 x 800|
|Ask||19.36 x 900|
|Day's Range||19.15 - 19.55|
|52 Week Range||14.48 - 31.35|
|Beta (5Y Monthly)||0.92|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.75|
Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will participate in an investor event as follows:
Theravance's (TBPH) loss narrows in the first quarter of 2021 while revenues decline year over year.
TBPH earnings call for the period ending March 31, 2021.